Andrew Krouse has over a decade of biotech investing and leadership experience with a track record of success as the founder and CEO of Tau Therapeutics, LLC, Xdynia LLC, and venture backed Cavion, Inc.
Andy has been recognized for his leadership in the industry as a CIT GAP 50 Entrepreneur in the Commonwealth of Virginia, a member of the Board of SEBIO, and is the immediate past Chairman of the Virginia Biotechnology Association.
Prior to his experience in the pharmaceutical industry, Andy worked as an analyst for Goldman Sachs, NYC, and served as Vice President of the UVA Darden Graduate School of Business. Most recently, he led the acquisition of UVA startup, Cavion, to industry leader Jazz Pharmaceuticals.
- M.A., Georgetown University
- B.S., University of Maryland